C3orf52 and pancreatic adenocarcinoma: C3orf52 (TTMP) was described as a tumor suppressor in pancreatic adenocarcinoma cell line28; in our study, it was downregulated in tumor tissue and correlated with stage and overall survival of ccRCC patients.